Table 4.
Mean Total Bleeding Days Weeks 1–3
Week | Type of Bleeding | Overall (n=37) | Normal Weight (n=18) | Obese (n=19) | P-Value |
---|---|---|---|---|---|
| |||||
Week 1 | Bleeding | 0.8 ± 1.3 | 0.3 ± 0.8 | 1.2 ± 1.6 | 0.06 |
Spotting | 1.1 ± 1.1 | 0.7 ±0.8 | 1.6 ± 1.3 | 0.02 | |
Bleeding or Spotting | 1.9 ± 1.8 | 1.0 ± 1.0 | 2.7 ± 2.0 | 0.002 | |
| |||||
Week 2 | Bleeding | 0.3 ± 1.0 | 0.1± 0.5 | 0.4 ± 1.3 | 0.4 |
Spotting | 0.1 ± 0.4 | 0.1 ± 0.2 | 0.2 ± 0.5 | 0.3 | |
Bleeding or Spotting | 0.4 ± 1.3 | 0.2 ± 0.7 | 0.6 ± 1.7 | 0.3 | |
| |||||
Week 3 | Bleeding | 0.1 ± 0.3 | 0.1 ± 0.3 | 0.1 ± 0.2 | 0.5 |
Spotting | 0.2 ± 0.6 | 0.1 ± 0.3 | 0.3 ± 0.7 | 0.5 | |
Bleeding or Spotting | 0.3 ± 0.7 | 0.2 ± 0.7 | 0.3 ± 0.8 | 0.7 | |
| |||||
Weeks 1–3 Overall | Bleeding | 1.1 ± 1.6 | 0.6 ± 1.0 | 1.6 ± 1.9 | 0.04 |
Spotting | 1.5 ± 1.7 | 0.8 ± 1.0 | 2.0 ± 1.9 | 0.03 | |
Bleeding or Spotting | 2.6 ± 2.7 | 1.4 ± 1.7 | 3.6 ± 3.0 | 0.01 |
Mean EE2 levels during contraceptive vaginal ring use